145 related articles for article (PubMed ID: 34096837)
1. Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project.
Baumgärtner J; Grohmann R; Bleich S; Glocker C; Seifert J; Toto S; Rüther E; Engel RR; Stübner S
World J Biol Psychiatry; 2022 Feb; 23(2):151-164. PubMed ID: 34096837
[TBL] [Abstract][Full Text] [Related]
2. Severe parkinsonism under treatment with antipsychotic drugs.
Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566
[TBL] [Abstract][Full Text] [Related]
3. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project.
Druschky K; Bleich S; Grohmann R; Engel RR; Neyazi A; Stübner S; Toto S
World J Biol Psychiatry; 2019 Nov; 20(9):732-741. PubMed ID: 30058414
[No Abstract] [Full Text] [Related]
4. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.
Glocker C; Grohmann R; Engel R; Seifert J; Bleich S; Stübner S; Toto S; Schüle C
Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1425-1435. PubMed ID: 33768297
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015.
Schneider M; Regente J; Greiner T; Lensky S; Bleich S; Toto S; Grohmann R; Stübner S; Heinze M
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):23-33. PubMed ID: 30506147
[TBL] [Abstract][Full Text] [Related]
6. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study.
Druschky K; Toto S; Bleich S; Baumgärtner J; Engel RR; Grohmann R; Maier HB; Neyazi A; Rudolph YJ; Rüther E; Schwörer H; Seifert J; Stübner S; Degner D
World J Biol Psychiatry; 2021 Jun; 22(5):373-386. PubMed ID: 32892689
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.
Glocker C; Grohmann R; Burkhardt G; Seifert J; Bleich S; Held T; Toto S; Stübner S; Schüle C
J Neural Transm (Vienna); 2023 Feb; 130(2):153-163. PubMed ID: 36653686
[TBL] [Abstract][Full Text] [Related]
8. Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study.
Grohmann R; Engel RR; Möller HJ; Rüther E; van der Velden JW; Stübner S
Eur Arch Psychiatry Clin Neurosci; 2014 Mar; 264(2):131-41. PubMed ID: 23835526
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013.
Friedrich ME; Winkler D; Konstantinidis A; Huf W; Engel R; Toto S; Grohmann R; Kasper S
Int J Neuropsychopharmacol; 2020 Feb; 23(2):67-75. PubMed ID: 31504560
[TBL] [Abstract][Full Text] [Related]
10. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries.
Druschky K; Bleich S; Grohmann R; Burda K; Frieling H; Hillemacher T; Neyazi A; Stübner S; Toto S
Eur Psychiatry; 2018 Oct; 54():117-123. PubMed ID: 30193142
[TBL] [Abstract][Full Text] [Related]
11. Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.
Rani FA; Byrne PJ; Murray ML; Carter P; Wong IC
Drug Saf; 2009; 32(4):325-33. PubMed ID: 19388723
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.
Seifert J; Maier HB; Führmann F; Bleich S; Stübner S; Sieberer M; Bernegger X; Greil W; Schüle C; Toto S; Grohmann R; Reinhard MA
J Neural Transm (Vienna); 2022 Jul; 129(7):925-944. PubMed ID: 35524828
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study.
Zolk O; Greiner T; Schneider M; Heinze M; Dahling V; Ramin T; Grohmann R; Bleich S; Zindler T; Toto S; Seifert J
World J Biol Psychiatry; 2022 Jun; 23(5):374-386. PubMed ID: 34907857
[TBL] [Abstract][Full Text] [Related]
14. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
16. Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017.
Seifert J; Engel RR; Bernegger X; Führmann F; Bleich S; Stübner S; Sieberer M; Greil W; Toto S; Grohmann R
J Affect Disord; 2021 Feb; 281():547-556. PubMed ID: 33401143
[TBL] [Abstract][Full Text] [Related]
17. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.
Lertxundi U; Ruiz AI; Aspiazu MÁ; Domingo-Echaburu S; García M; Aguirre C; García-Moncó JC
Clin Neuropharmacol; 2015; 38(3):69-84. PubMed ID: 25970275
[TBL] [Abstract][Full Text] [Related]
19. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.
Bender S; Grohmann R; Engel RR; Degner D; Dittmann-Balcar A; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S46-53. PubMed ID: 15052514
[TBL] [Abstract][Full Text] [Related]
20. Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database.
Guo K; Feng Z; Chen S; Yan Z; Jiao Z; Feng D
Front Pharmacol; 2022; 13():848472. PubMed ID: 35355731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
